Free Trial

Dianthus Therapeutics (DNTH) Insider Trading & Ownership

Dianthus Therapeutics logo
$20.77 -1.50 (-6.74%)
(As of 11/20/2024 ET)

Dianthus Therapeutics (NASDAQ:DNTH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.56%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$1.31 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get DNTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Dianthus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DNTH Insider Buying and Selling by Quarter

Dianthus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/29/2023Fairmount Funds Management LlcDirectorBuy24,670$13.63$336,252.10  
9/26/2023Fairmount Funds Management LlcDirectorBuy30,000$13.15$394,500.00  
9/21/2023Simrat RandhawaInsiderBuy2,000$13.20$26,400.00  
9/19/2023Fairmount Funds Management LlcDirectorBuy30,000$13.20$396,000.00  
9/12/2023Fairmount Funds Management LlcDirectorBuy14,887$10.85$161,523.95  
(Data available from 1/1/2013 forward)

DNTH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Dianthus Therapeutics includes Fairmount Funds Management Llc, and Simrat Randhawa. Learn more on insiders at DNTH.

16.56% of Dianthus Therapeutics stock is owned by insiders. Learn more on DNTH's insider holdings.

The following insiders have purchased DNTH shares in the last 24 months: Fairmount Funds Management Llc ($1,288,276.05), and Simrat Randhawa ($26,400.00).

Insiders have purchased a total of 101,557 DNTH shares in the last 24 months for a total of $1,314,676.05 bought.

Dianthus Therapeutics Key Executives

  • Mr. Marino Garcia M.B.A. (Age 58)
    President, CEO, Secretary & Director
    Compensation: $496.02k
  • Mr. Ryan Savitz (Age 35)
    CFO and Chief Business Officer & Treasurer
    Compensation: $329.65k
  • Mr. Simrat Randhawa M.B.A. (Age 54)
    M.D., Chief Medical Officer
    Compensation: $338.16k
  • Mr. Edward G. Carr (Age 55)
    Chief Accounting Officer
  • Mr. Judson Taylor
    Head of Technical Operations
  • Dr. Jeffrey Stavenhagen Ph.D.
    Chief Scientific Officer
  • Ms. Jennifer Davis Ruff
    VP and Head of Investor Relations & Corporate Affairs.
  • Mr. Adam M. Veness Esq. (Age 38)
    Senior VP, General Counsel & Secretary
  • Ms. Kristina Maximenko
    Chief People Officer
  • Ms. Rashieda Gluck
    Head of Clinical Development Operations


This page (NASDAQ:DNTH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners